Boston Scientific Corporation (NYSE:BSX) stock is up today following news of a settled lawsuit.

The lawsuit was between Boston Scientific and Johnson & Johnson (NYSE:JNJ). The lawsuit will have BSX paying JNJ $600 million. This is much less than the $7 billion Johnson & Johnson was seeking for damages in the lawsuit, reports The New York Times.

The cause of the lawsuit goes back to 2004 when Johnson & Johnson attempted to buy Guidant. Guidant broke its agreement in the deal and sought out a higher buyer in Boston Scientific, which ultimately bought it. The conclusion of this lawsuit makes amends for Guidant breaking its agreement with Johnson & Johnson, NYT notes.

“We view this resolution as a significant positive for Boston Scientific, lifting what has been a major overhang over the past few months,” Michael Weinstein , a J.P. Morgan analyst, told The Wall Street Journal.

BSX shares were up 10% as of Noon Wednesday.

More From InvestorPlace